Journal of Pharmaceutical Chemistry

Aim and Scope

The Journal of Pharmaceutical Chemistry covers scientific and technical aspects of new drug development and improved manufacturing technology pertaining to drugs and intermediates.

The submitted manuscripts are classified under any one of the four classes indicated below to enable easier management. Each of these subclasses has its aim and scope that help us maintain the journal theme.

Organic Synthesis and Medicinal Chemistry

Manuscripts dealing with molecular modeling, drug design, organic synthesis, and medicinal chemistry are published under this section. Theoretical studies will be accepted only when supported with appropriate experimental data. Novelty in either synthesis or biological activity is expected for consideration of the manuscript for publication.

Pharmaceutical Formulation and Analysis

This class handles manuscripts related to the formulation of novel drug delivery systems, their characterization, and studies on their in-vitro and in-vivo release profile. This also includes the design, development, and validation of analytical methods per guidelines of regulatory authorities (FDA, EMEA, ICH, WHO, etc.). The journal encourages the submission of articles where a novel or modified drug/excipient is being used to improve the formulation.

Phytochemistry and Ethnomedicine

This class handles manuscripts in the area of purification, isolation, and characterization of biologically active materials from natural sources. Reports on the biological activity of aqueous/methanolic extracts are strongly discouraged. To be considered for publication, the establishment of active fractions along with their HPLC/ HPTLC fingerprinting and appropriate use of biomarkers is recommended. When reporting the isolation of an active component, complete characterization data should be presented (Elemental analysis, UV, IR, HR-MS, 1H-NMR, 13C-NMR, etc.)

Biochemistry and Molecular Pharmacology

This class handles manuscripts in the area of in-vitro biochemical method & in-vivo pharmacological model development, validation, and application in the area of drug discovery and development. Simulation studies with appropriate experimental results along with correlation data will be considered for publication. Studies involving animals should be submitted along with an appropriate institutional committee’s ethics approval certificate/letter.

JPC accepts manuscripts for three major categories: Research Articles, Research Communications and Research Reviews. Exceptionally informative short communications are also accepted.

Peer Review Process

JPC follows “Double-Blind Review”. This means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. Three reviewers will review manuscripts and the opinion of two reviewers will be required for considering the manuscript for publication. Each reviewer will be provided a minimum period of three weeks to submit their report. The JPC Editorial team will take all necessary steps to ensure a smooth flow of the review process and manuscript publication within a reasonable time.

Publication Frequency

JPC is now moving from Quarterly to Annual issues and will follow the policy of ‘Publish upon Acceptance’.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.